| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,923 | 0,931 | 12:01 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11:15 | Transgene erweitert Lizenzvereinbarung mit ProBioGen | Transgene und ProBioGen bauen ihre bestehende Zusammenarbeit aus. Das französische Biotech-Unternehmen hat eine zusätzliche Lizenz für die Zelllinie AGE1.CR.pIX von ProBioGen vereinbart. Transgene will... ► Artikel lesen | |
| 07:36 | Transgene S.A.: Transgene and ProBioGen Expand Strategic Partnership with Additional License Agreement for AGE1.CR.pIX Cell Line | Strasbourg (France), Berlin (Germany), September 8, 2026, 7:30 a.m. CEST - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment... ► Artikel lesen | |
| Mi | Transgene S.A.: Transgene and NEC Corporation Report 100% Three-Year Disease-Free Survival with TG4050 and Publish Phase 1 Results in Nature Communications | TG4050 as a single agent has the potential to prevent recurrence in head and neck cancer Peer-reviewed publication in Nature Communications highlights the Phase 1 clinical and translational findings... ► Artikel lesen | |
| 07.07. | Transgene S.A.: Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2026 | ||
| 25.06. | Transgene S.A.: Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line-Derived MVA Vaccine Candidate (TG MVA) at WCID 2026 |
